5 Result: Accenture
Earnings Countdown: Accenture, NIKE, and Micron Technology Brace for Reports
March 16th, 2025
Several high-profile companies are set to announce their latest financial results on Thursday, March 20, including: Accenture plc (NYSE: ACN), a global consulting and IT services firm, will report its second-quarter fiscal 2025 earnings before the. Read more
Eyes on the Numbers: Accenture, FedEx, and FactSet's Earnings Preview
December 16th, 2023
On Tuesday, December 19, several prominent companies are scheduled to unveil their financial performance, including: Accenture plc (NYSE: ACN), a global professional services firm, is set to release its first-quarter fiscal 2024 financial results . Read more
Setback for BrainStorm Cell Therapeutics; Accenture Posts Mixed Results
September 28th, 2023
BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a biotechnology company that specializes in developing innovative stem cell therapies for neurodegenerative diseases, faced a setback as the U.S. Food and Drug Administration's Cellular, Tissue, and G. Read more
Earnings Spotlight: Accenture, NIKE, and Jabil on the Horizon
September 24th, 2023
On Thursday, September 28, a number of companies are scheduled to announce their financial results, including: Accenture plc (NYSE: ACN), a global consulting and professional services firm, is set to announce its fourth-quarter and full-year fisca. Read more
Evaxion Biotech: Promising EVX-01 Clinical Data; Celsius, Accenture, Five Below: PT Raised
June 04th, 2023
Evaxion Biotech A/S (Nasdaq: EVAX) announced encouraging findings from its EVX-01 Phase 1 clinical trial, which assessed the safety and effectiveness of EVX-01 in combination with a checkpoint inhibitor for metastatic melanoma patients. Acco. Read more
Member Login